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The Journal of Immunology
Antigen-Presenting Human gd T Cells Promote Intestinal
CD4+ T Cell Expression of IL-22 and Mucosal Release of
Calprotectin
Christopher J. Tyler,*,1,2 Neil E. McCarthy,†,1 James O. Lindsay,†,‡ Andrew J. Stagg,†
Bernhard Moser,*,x and Matthias Eberl*,x
The cytokine IL-22 plays a critical role in mucosal barrier defense, but the mechanisms that promote IL-22 expression in the human
intestine remain poorly understood. As human microbe–responsive Vg9/Vd2 T cells are abundant in the gut and recognize
microbiota-associated metabolites, we assessed their potential to induce IL-22 expression by intestinal CD4+ T cells. Vg9/Vd2
T cells with characteristics of APCs were generated from human blood and intestinal organ cultures, then cocultured with naive
and memory CD4+ T cells obtained from human blood or the colon. The potency of blood and intestinal gd T-APCs was compared
with that of monocytes and dendritic cells, by assessing CD4+ T cell phenotypes and proliferation as well as cytokine and
transcription factor profiles. Vg9/Vd2 T cells in human blood, colon, and terminal ileum acquired APC functions upon microbial
activation in the presence of microenvironmental signals including IL-15, and were capable of polarizing both blood and colonic
CD4+ T cells toward distinct effector fates. Unlike monocytes or dendritic cells, gut-homing gd T-APCs employed an IL-6
independent mechanism to stimulate CD4+ T cell expression of IL-22 without upregulating IL-17. In human intestinal organ
cultures, microbial activation of Vg9/Vd2 T cells promoted mucosal secretion of IL-22 and ICOSL/TNF-a–dependent release of
the IL-22 inducible antimicrobial protein calprotectin without modulating IL-17 expression. In conclusion, human gd T-APCs
stimulate CD4+ T cell responses distinct from those induced by myeloid APCs to promote local barrier defense via mucosal release
of IL-22 and calprotectin. Targeting of gd T-APC functions may lead to the development of novel gut-directed immunotherapies
and vaccines. The Journal of Immunology, 2017, 198: 000–000.
E
ffective host protection against pathogens requires dy-
namic cross-talk between leukocytes and non-immune
cells at epithelial barrier sites including the skin, lung,
and intestine, as well as continuous interaction with the com-
mensal microbiota that populate these tissues (1, 2). A key
regulator of epithelial integrity and immunity is the cytokine
IL-22, which induces secretion of antimicrobial peptides, acute
phase proteins and mucins, and drives neutrophil recruitment via
production of chemokines (3). The multiple effects of IL-22
mediate epithelial barrier protection in the steady state but can
also induce tissue pathology when dysregulated; hence this cy-
tokine has been implicated in inflammatory disorders of epi-
thelial surfaces including psoriasis and inflammatory bowel
disease (IBD) (4–6).
Gut-resident innate lymphoid cells (ILCs) are major producers of
IL-22 in the mouse intestine (7), but there is a conspicuous re-
duction in IL-22–producing ILC numbers toward the distal end of
the digestive tract, suggesting that other cell types may comple-
ment the role of IL-22+ ILCs (8, 9). Indeed, the IL-22+ ILC
population may be functionally redundant in the human gut pro-
vided that CD4+ T cells, which are prominent sources of IL-22
during intestinal inflammation, are present (10, 11). The immu-
nological mechanisms that induce IL-22 expression in mucosal
T cells are poorly understood. IL-22 is typically coexpressed with
IFN-g and/or IL-17 by cells belonging to the Th1 and Th17
lineages, respectively. However, growing evidence also suggests
the existence of a distinct Th22 lineage that expresses IL-22
without IL-17 or IFN-g (12–15). Indeed, human skin–derived
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Langerhans cells have been reported to induce a distinct pop-
ulation of IL-22+ CD4+ T cells that lack IL-17, although the
underlying molecular mechanism was not defined (14). Simi-
larly, circulating plasmacytoid dendritic cells (DCs) release
soluble factors including IL-6 and TNF-a, which stimulate
skin-homing CD4+ T cells to express IL-22 but not IL-17 (12).
Intestinal DCs have also been described to induce IL-22 ex-
pression in CD4+ T cells, but only in conjunction with other
cytokines including IFN-g, IL-17, and IL-10. The pathways
underpinning the specific induction of IL-22+ IL-172 CD4+
T cells in the human gut remains unknown (16).
Myeloid APCs may not be the only Ag-presenting populations
in the intestine that can modulate local CD4+ T cell responses.
Indeed, microbe-responsive Vg9/Vd2 T cells in the human gut
express APC markers, influence colonic CD4+ T cell function
(17), and may contribute to the pathology of IBD (18). Whereas
they are absent in rodents, Vg9/Vd2 T cells typically represent
1–5% of total T cells in human blood and tissues including the
gut (17, 18). Intriguingly, Vg9/Vd2 T cells readily acquire APC
characteristics in vitro, induce naive and memory CD4+ and
CD8+ T cell responses (19, 20), and thus possess considerable
potential for immunotherapeutic applications. However, little is
known about the capacity of such gd T-APCs to polarize CD4+
T cell responses, especially in anatomical compartments other
than blood.
In this report, we demonstrate that human microbe–responsive
Vg9/Vd2 T cells readily acquire gut-homing and Ag-presenting
functions, and stimulate CD4+ T cell responses distinct from those
induced by monocytes or DCs. Unlike myeloid APCs, blood and
intestinal gd T-APCs failed to promote IL-17 but were capable of
potent IL-22 induction in naive and memory CD4+ T cells via a
costimulatory pathway that required inducible T-cell costimulator
ligand (ICOSL) and TNF-a but not IL-6. Selective induction of
IL-22 responses in human intestinal CD4+ T cells without parallel
upregulation of IL-17 is likely to promote barrier integrity and
mediate host protection against pathological inflammation (21),
consistent with a critical role for gd T cells in the immuno-
surveillance of peripheral tissues (22).
Materials and Methods
Ethical approval
Recruitment of patients and healthy volunteers was conducted according
to the principles expressed in the Declaration of Helsinki and approved
under reference numbers 05/Q0405/71, Harrow Research Ethics Com-
mittee; 10/H0704/74, East London Research Ethics Committee 2; P/01/
023, East London and City Health Authority Research Ethics Committee;
and 08/WSE04/17, South East Wales Local Ethics Committee. All in-
dividuals provided written informed consent prior to inclusion in the
study.
Media, reagents, and Abs
For T cell cultures, RPMI 1640 was supplemented with 10% FCS, 50 mg/ml
penicillin/streptomycin, 2 mM L-glutamine, 1% sodium pyruvate, and 100 mM
non-essential amino acids (Life Technologies). For tissue samples,
Dutch-modified RPMI 1640 medium was supplemented with 10% FCS,
2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin, and
25 mg/ml gentamicin (Sigma). Synthetic (E)-4-hydroxy-3-methyl-but-2-enyl
pyrophosphate (HMB-PP) was purchased from Echelon Biosciences. Toxic
shock syndrome toxin-1 (TSST-1) was purchased from Toxin Technology;
purified protein derivative (PPD) was from Statens Serum Institut,
Copenhagen, Denmark. Salmonella abortus equi LPS, peptidoglycan
(PGN), PMA, ionomycin, and brefeldin A were purchased from Sigma.
CFSE was purchased from Life Technologies. Recombinant IL-1b, IL-4,
IL-6, IL-12, IL-15, IL-23, GM-CSF, and TNF-a were purchased from
Miltenyi; IL-7 from Peprotech; and TGF-b from BD Biosciences.
Recombinant IL-2 (Proleukin) was from Chiron; IL-21 was from
Zymogenetics.
For surface phenotyping, anti-CD4:APC-H7 (RPA-T4), anti-CD45RA:
APC (HI100), anti-CD83:PE-Cy7 (HB15c), anti-TCR-Vd2:PE (B6.1),
and anti-HLA-DR:APC-H7 (L243) from BD Biosciences; anti-CD40:PE
(mAB89) and anti-TCR-Vg9:PE-Cy5 (Immu360) from Beckman Coulter;
anti-CD25:APC (BC96), anti-CD70:FITC (113-16) and anti-CD80:FITC
(2D10.4) from eBioscience; and anti-CD3:BV421 (UCHT-1), anti-CD14:
BV421 (M5E2), anti-CD86:APC (IT2.2), anti-ICOSL:PE (2D3), anti-
CCR7:PE-Cy7 (G043H7), anti-CCR9:AF647 (L053E8), anti-CLA:FITC
(HECA-452) and anti-integrin b7 (FIB504) from BioLegend were used,
together with appropriate isotype controls. Intracellular cytokines were
detected using anti-IFN-g:BV421 (4S.B3; BioLegend), anti-IL-17A:APC
(eBio64DEC17; eBioscience), and anti-IL-22:PE-Cy7 (22URTI; eBio-
science).
Blocking reagents used were anti-IFN-g (B27), anti-IL-4 (8D4-8), and
anti-IL-6 (MQ2-13A5) from BioLegend; and soluble TNF-a receptor
(sTNFR) p75-IgG1 fusion protein (etanercept/Enbrel; Amgen). Agonistic
reagents included anti-CD3 (OKT3), anti-CD28 (CD28.2), and anti-ICOS
(ISA-3) from eBioscience. Soluble CD70 (sCD70) was provided by Jannie
Borst, the Netherlands Cancer Institute.
Tissue samples
Biopsies of colonic mucosa were obtained from patients undergoing
colonoscopy for cancer screening or investigation of rectal bleeding but
with no significant findings. Additional mucosal tissue (terminal ileum
and colon) was obtained from patients undergoing surgical resection for
colorectal cancer or for non-inflammatory intestinal motility disorders.
Endoscopic biopsies or equivalently sized pieces of resected intestinal
tissue were washed in calcium- and magnesium-free HBSS containing
1 mM DTT (Sigma) for 15 min to remove mucus and feces, followed by
incubation in 1 mM EDTA for 1 h under constant shaking to remove the
epithelium. Mucosal tissue pieces were then transferred into 24-well
plates for organ cultures in complete tissue medium containing 30 U/ml
IL-2 and 20 ng/ml IL-15, in the presence or absence of 10 nM HMB-PP.
After 3 d, intact tissues were discarded and the egressed leukocytes seeded
into 96-well, round-bottom plates for a further 4 d. At the end of the
culture period, intestinal Vd2+ T cells and CD4+ T cells were each sorted
to .99.2% purity.
Cell isolation from blood and APC generation
PBMC were isolated from heparinized venous blood of healthy donors or
from blood bags supplied by the Welsh Blood Service (Velindre National
Health Service Trust) using Lymphoprep (Axis-Shield). CD14+ monocytes
(.99% purity) were purified from PBMC using anti-CD14 microbeads
(Miltenyi). Immature DCs (iDCs) were derived from monocytes over 5–
6 d in the presence of 50 ng/ml GM-CSF and 50 ng/ml IL-4. Maturation of
iDCs into mature DCs (mDCs), and activation of freshly isolated mono-
cytes was achieved via stimulation for 24 h with 100 ng/ml LPS or 1 mg/ml
PGN. Vg9+ T cells and Vd2+ T cells (each .99% purity) were isolated
using anti-TCR-Vg9:PECy5 (Beckman Coulter) or anti-TCR-Vd2:PE
mAbs (BD Biosciences), combined with anti-PE microbeads (Miltenyi).
gd T-APCs were generated by coculture of purified blood Vg9/Vd2 T cells
with irradiated monocytes (50 Gy) at a 10:1 ratio, in the presence of 10 nM
HMB-PP with or without 100 U/ml IL-2 or 20 ng/ml IL-7, IL-15, or IL-21.
gd T-APCs were cultured for 3 d and further purified either by positive
selection or cell sorting to purities .99.2%. Bulk CD4+ T cells (.95%
purity) were isolated from PBMC via negative selection using the CD4+
T cell Isolation Kit (Miltenyi). For isolation of naive and memory sub-
sets, bulk CD4+ T cells were labeled with anti-CD4, anti-CD45RA, and
anti-CCR7 mAbs prior to sorting using a FACSAria II (BD Biosciences) to
obtain naive (CD4+ CD45RA+ CCR7+) and memory (CD4+ CD45RA2
CCR72) populations of .99.4% purity.
Generation of polarized T helper subsets
Naive CD4+ T cells were polarized in anti-CD3 coated flat-bottom 96-well
plates (5 mg/ml for Th1 cells, 2.5 mg/ml for all other conditions) in the
presence of 1 mg/ml anti-CD28 together with the following reagents: Th1,
100 U/ml IL-2, 20 ng/ml IL-12, and 10 mg/ml anti-IL-4; Th2, 20 ng/ml IL-4
and 10 mg/ml anti-IFN-g; Th17, 20 ng/ml IL-1b, 50 ng/ml IL-6, 2 ng/ml
TGF-b, and 10 mg/ml each of anti-IL-4 and anti-IFN-g; and Th22, 50 ng/ml
IL-6, 20 ng/ml TNF-a, and 10 mg/ml each of anti-IL-4 and anti-IFN-g.
APC assays
For MLRs, APCs and allogeneic CD4+ T cells were cocultured at a 1:10
ratio. gd T-APCs were irradiated at 12 Gy prior to coculture with responder
cells. For Ag-restricted responses, APCs were pulsed with 1 ng/ml TSST-1
for 1 h and washed three times prior to coculture with autologous CD4+
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T cells. To assess CD4+ T cell responses to complex Ag preparations,
APCs were cultured with 1 mg/ml PPD for the final 24 h of APC gener-
ation and washed three times prior to coculture with autologous CD4+
T cells. Cocultures were incubated for 5 d for proliferation assays using
CFSE-labeled responder cells, or for 9 d for analysis of cytokine and
transcription-factor expression. For blocking of costimulatory molecules,
APCs were preincubated with neutralizing mAbs for 2–3 h and washed three
times, prior to addition of CD4+ T cells. For inhibition of APC-derived
cytokines, appropriate blocking reagents were added directly to MLR assays.
Cell migration
Migration assays were performed in 96-well HTS transwell plates with 5 mm
pores (Corning) using RPMI 1640 supplemented with 5% human serum al-
bumin and 1 mM HEPES (Sigma) as chemotaxis buffer. Serial dilutions of
CCL25 (maximum concentration 1 mg/ml) were added to the lower cham-
bers, and chemotaxis buffer was used as a negative control. A total of 100,000
gd T-APCs were seeded into the upper chambers. After 3 h, the percentage of
cells that had migrated to the lower chamber was assessed using AccuCheck
counting beads (Thermo Fisher).
Flow cytometry
Cells were acquired on an eight-color FACSCanto II (BD Biosciences) and
analyzed with FlowJo 10.1 (TreeStar). Anti-mouse Ab reactive beads were
used to set compensation (Life Technologies). Single leukocytes were gated
based on light scatter characteristics and exclusion of fixable Aqua Dead Cell
Stain (Invitrogen), followed by gating based on fluorescence minus one
controls. For detection of intracellular cytokines, cells were restimulated with
10 ng/ml PMA and 1 mM ionomycin for 5 h, and cultures were supplemented
with 10 mg/ml brefeldin A during the last 4 h of the incubation period.
Quantitative PCR
CD4+ T cell responders were sorted from cocultures with irradiated APCs to
purities .99.1%. Total RNA was extracted using the RNeasy Micro
Kit (Qiagen), and used to generate cDNA with the SuperScript VILO cDNA
Synthesis Kit (Thermo Fisher). Transcripts were quantified by real-time
quantitative PCR using the ViiA7 Real-Time PCR System (Thermo Fisher).
Predesigned TaqMan Gene Expression Assays and the Taqman Universal
Master Mix II (no UNG) were used according to the manufacturer’s instruc-
tions: T-box transcription factor 21 (TBX21), Hs00203436_m1; retinoid-related
orphan receptor-g (RORC), Hs01076112_m1; aryl hydrocarbon receptor
(AHR), Hs00169233_m1; and PPIL2, Hs00204962_m1 (all from Thermo
Fisher). All samples were measured in triplicate. Measured mRNA abundance
was normalized to PPIL2 (cyclophilin) using the ExpressionSuite Software
(Thermo Fisher), and is presented as arbitrary units.
ELISA
Cell-free supernatants from resting or stimulated Vg9/Vd2 T cell, DC, or
monocyte cultures were collected after 3 d incubation. Supernatants from
50,000 polarized CD4+ T cells were collected after 24 h incubation with
10 ng/ml PMA and 1 mg/ml ionomycin. Supernatants from intestinal tissue
cells were collected after 3 d in culture. Soluble cytokines were detected
using conventional ELISA kits for IFN-g and calprotectin (BioLegend);
TNF-a, IL-10, IL-17, IL-22, and IL-23 (eBioscience); and IL-1b, IL-6,
and IL-12p70 (R&D Systems). All samples were measured in duplicate on
a Dynex MRX II reader.
Statistical analysis and data presentation
Statistical analyses were performed using GraphPad Prism 6.0 software.
Data distributions were analyzed using D’Agostino–Pearson omnibus
FIGURE 2. Gut-homing potential of gd T-APCs. (A) Expression of b7
integrin, CCR9, and CLA by gdIL-15 T-APCs on day 3 of culture. (B)
Expression of gut and skin homing markers by gd T-APCs generated in
the presence of the indicated cytokines, as gated on live single Vg9+
T cells. (C) Migration of gdIL-15 T-APCs toward CCL25, shown as
percentage of total input cells. Data in (B) were analyzed using Kruskal–
Wallis tests combined with Dunn multiple comparison tests compared
with controls in the absence of APCs. FACS plots are representative of
$4 experiments using cells from $4 donors; numbers indicate per-
centages. *p , 0.05, **p , 0.01.
FIGURE 1. Human mucosal gd T cells exhibit potent APC activity. (A)
Blood-derived naive CD4+ T cell responses to allogeneic gd T-APCs from
the human colon, shown as CFSE dilution and cytokine expression upon
restimulation after 9 d. (B and C) Expression of APC markers by human
gut-derived Vg9/Vd2 T cells among total colon cells after 7 d in culture, as
gated on live single Vg9+ T cells, compared with unstimulated controls.
Data were analyzed using Wilcoxon matched-pairs signed rank tests.
FACS plots are representative of $4 experiments using HMB-PP stimu-
lated cells from $4 donors; numbers indicate percentages together with
mean fluorescence intensity (MFI) values for ICOSL expression.
The Journal of Immunology 3
 by guest on M
arch 22, 2017
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
normality tests. Data were analyzed using two-tailed Student t tests for
normally distributed data and two-tailed Mann–Whitney U tests for non-
parametric data. Differences between groups were analyzed using one-way
ANOVA with Holm–Sidak’s post tests for multiple comparisons of para-
metric data, or Kruskal–Wallis tests combined with Dunn post tests for
non-parametric data. Matched data were analyzed using paired t tests or
Wilcoxon matched pairs tests for two groups, or Friedman tests combined
with Dunn multiple comparison tests for more than two groups. In the
graphs, each data point represents an individual donor; statistically sig-
nificant differences are *p , 0.05, **p , 0.01, and ***p , 0.001. Hor-
izontal lines display the median and error bars indicate the interquartile
range.
Results
Human gut gd T cells polarize naive CD4+ T cells toward
production of IFN-g and IL-22
To assess the potential of gd T cells to exert APC functions in the
human gut, colonic organ cultures were either left untreated or
stimulated with the microbial Vg9/Vd2 T cell ligand HMB-PP,
which is produced by the majority of intestinal commensals (23,
24), in the presence of the T cell growth factors IL-2 and IL-15.
Egressed Vg9/Vd2+ gd T cells were sorted to purity and
cocultured with naive CD4+ T cells from allogeneic blood do-
nors. Colonic Vg9/Vd2 T cells from HMB-PP–stimulated gut
tissue displayed an increased ability to induce proliferation and
differentiation of naive CD4+ T cells toward expression of IFN-g
and IL-22, compared with unstimulated controls (Fig. 1A),
whereas only trace numbers of IL-17+ CD4+ T cells were gen-
erated in these cocultures. Similar results were obtained with
human ileum (data not shown), demonstrating that Vg9/Vd2
T cells in both the small and large intestine exert comparable
effects on CD4+ T cell responses. These functional data were
reflected by the expression of MHC class II and costimulatory
molecules commonly associated with APCs (Fig. 1B). Egressed
gut Vg9/Vd2 T cells already expressed intermediate levels of
HLA-DR, CD86, CD70, and ICOSL at baseline, and all bar
CD70 were markedly upregulated in response to exogenous
HMB-PP (Fig. 1C). These data indicate that intestinal Vg9/Vd2
T cells display APC features ex vivo.
Microbe-responsive gd T cells acquire a gut-homing APC
phenotype upon TCR triggering in a cytokine-dependent manner
In support of a role in the intestine, blood Vg9/Vd2 T cells
stimulated with HMB-PP in the presence of either IL-2 (gdIL-2
T-APCs) or IL-15 (gdIL-15 T-APCs) expressed b7 integrin and the
small bowel-homing chemokine receptor CCR9 but only trace
levels of the skin-homing cutaneous lymphocyte–associated Ag
(CLA) (Fig. 2A, 2B). These data evoke our previous report that
upregulation of the a4b7 heterodimer on blood Vg9/Vd2 T cells is
accompanied by increased binding to the mucosal addressin
MAdCAM-1 as well as decreased CLA expression (17). Whereas
IL-2 and IL-15 each supported upregulation of a gut-tropic Vg9/Vd2
T cell phenotype, the closely related cytokines IL-7 and IL-21
failed to induce CCR9 (Fig. 2B). Confirming a functional role
for CCR9, gdIL-15 T-APCs readily migrated toward its ligand
CCL25 (Fig. 2C).
When combined with TCR triggering, both IL-2 and IL-15 also
supported Vg9/Vd2 T cell upregulation of HLA-DR, CD86,
CD70, and ICOSL (Fig. 3A), as well as expression of CD40,
CD80, CD83, and the lymph node–homing receptor CCR7
FIGURE 3. Naive CD4+ T cell polarization by gd T-APCs. (A) Expression of APC markers by freshly isolated Vg9/Vd2 T cells and by Vg9/Vd2 T cells
cocultured for 3 d with irradiated autologous monocytes in the presence of HMB-PP with the indicated cytokines, as gated on live single Vg9+ T cells. (B)
Proliferation of CFSE-labeled naive CD4+ T cells in response to allogeneic gd T-APCs generated under different conditions, compared with iDCs, LPS or
PGN-matured DCs (mDCLPS, mDCPGN), freshly isolated monocytes (mono), and LPS- or PGN-stimulated monocytes (monoLPS, monoPGN). (C) Polari-
zation of naive CD4+ T cells by allogeneic gd T-APCs generated under different conditions, compared with mDCPGN, as determined after 9 d upon
restimulation. Transcription factors were measured after FACS sorting of polarized CD4+ T cells from APC cocultures. Relative expression was determined
relative to naive CD4+ T cells. Data were analyzed using Kruskal–Wallis tests combined with Dunn multiple comparison tests versus freshly isolated
cells (A) or controls in the absence of APCs (C). FACS plots are representative of $4 experiments using cells from $4 donors. *p , 0.05, **p , 0.01,
***p , 0.001. AU, artificial units.
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(Supplemental Fig. 1). In contrast, IL-21 induced only low or
intermediate levels of the APC markers tested in this study, and
IL-7 treated Vg9/Vd2 T cells did not exhibit any discernible APC
phenotype, thus serving as a negative control in subsequent
functional assays. These findings indicate that IL-2 and IL-15 play
crucial and distinct roles in the acquisition of a gut-homing APC
phenotype by human Vg9/Vd2 T cells.
gd T-APCs polarize naive CD4+ T cells toward distinct effector
phenotypes
When tested in MLRs, gd T-APCs readily induced naive CD4+
T cell proliferation. Both gdIL-2 and gdIL-15 T-APCs drove naive
CD4+ T cell proliferation with comparable efficiency to that dis-
played by monocyte-derived DCs matured in the presence of LPS
or PGN (Fig. 3B) (25). This effect was abrogated with neutralizing
mAbs against CD11a (data not shown), a treatment known to
disrupt the immunological synapse. gdIL-21 T-APCs displayed
weak APC activity, comparable with that of LPS-/PGN-stimulated
monocytes, whereas IL-7 treated Vg9/Vd2 T cells failed to induce
naive CD4+ T cell proliferation, in agreement with their observed
lack of HLA-DR expression (Fig. 3B).
When assessing the resulting effector functions of stimulated
CD4+ T cells, we observed striking outcomes depending on the
type of APC used. Unexpectedly, the ability of gdIL-15 T-APCs
to induce IL-22+ CD4+ T cells was far superior to that of DCs,
monocytes or any other population of gd T-APCs tested, as
judged by intracellular cytokine staining (Fig. 3C) and ELISA
(Supplemental Fig. 2A), pointing toward a unique capacity of
gdIL-15 T-APCs to promote IL-22 responses. Accordingly, gdIL-15–
stimulated CD4+ T cells expressed the highest levels of the
Th22 associated transcription factor AHR. Both gdIL-2 and
gdIL-15 T-APCs also efficiently polarized naive CD4
+ T cells
toward IFN-g production and expression of the Th1 associated
transcription factor TBX21 (Fig. 3C, Supplemental Fig. 2A).
Unlike PGN-treated DCs or monocytes, gd T-APCs failed to
give rise to IL-17+ CD4+ T cells despite background expres-
sion of the Th17 master switch retinoid-related orphan re-
ceptor-g (RORC) (Fig. 3C), which in human cells can be
expressed independently of IL-17 (25). A substantial propor-
tion of IL-22+ CD4+ T cells was negative for both IFN-g and
IL-17, thus representing bona fide Th22 cells (Supplemental
Fig. 2B). Taken together, these findings demonstrate that
FIGURE 4. Polarization of memory and Ag-specific CD4+ T cells by gd T-APCs. (A) Proliferation of CFSE-labeled memory CD4+ T cells in response to
allogeneic APCs, displayed as percentage of CFSElo cells. (B) Polarization of memory CD4+ T cells by allogeneic gdIL-15 T-APCs or mDCPGN, as de-
termined after 9 d upon restimulation. (C) Polarization of memory CD4+ T cells by allogeneic APCs. (D) Polarization of superantigen-specific naive CD4+
T cells in response to autologous APCs pulsed with TSST-1, within the Vb2+ CD4+ gate. (E) Polarization of microbial Ag-specific memory CD4+ T cells
in response to autologous APCs in the presence of PPD. Data were analyzed using Kruskal–Wallis tests combined with Dunn multiple comparison tests versus
controls in the absence of APCs. FACS plots are representative of $4 experiments using cells from $4 donors. *p , 0.05, **p , 0.01, ***p , 0.001.
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gd T-APC plasticity exerts a profound influence on the polariza-
tion of naive CD4+ T cells, and that gdIL-15 T-APCs display an
unexpected capacity to promote the differentiation of IL-22+
IL-172 CD4+ T cells.
gdIL-15 T-APCs enhance IL-22 responses in memory CD4
+
T cells
We next assessed whether gd T-APCs could similarly influence the
outcome of established effector/memory CD4+ T cell responses. As
with naive CD4+ T cells, both gdIL-2 and gdIL-15 T-APCs induced
memory CD4+ T cell proliferation with comparable efficiency to
that displayed by mDCs (Fig. 4A). Importantly, gdIL-15 T-APCs
were the most potent inducers of IL-22 expression, yielding up
to 40% IL-22+ memory CD4+ T cells (Fig. 4B, 4C). In contrast,
there was a negligible expansion of IL-17+ CD4+ T cells in
cocultures with gd T-APCs, as opposed to PGN-treated DCs.
Similar results were obtained using autologous responder cells,
demonstrating a clear ability of gdIL-15 T-APCs to induce IL-22
responses in autologous TSST-1 specific naive CD4+ T cells
(Fig. 4D), and in Mycobacterium tuberculosis PPD-specific mem-
ory CD4+ T cells (Fig. 4E). These findings demonstrate that gd
T-APCs can shape Ag-specific adaptive immune responses and in-
duce IL-22 production in both naive and memory CD4+ T cells.
gd T-APCs polarize CD4+ T cells via TNF-a and ICOSL
We next sought to identify the polarizing signals that facilitate
gd T-APC polarization of T cell responses (Fig. 5). Blocking
either CD80 or CD86 reduced naive CD4+ T cell proliferation
and cytokine production in response to allogeneic gdIL-15
T-APCs (Supplemental Fig. 3A), in agreement with the known
role of CD28 signaling in CD4+ T cell activation (26). The
induction of IL-22 and AHR expression in CD4+ T cells was
selectively impaired in the presence of sTNFR (Fig. 5A, 5B),
whereas blocking mAbs against IFN-g (Fig. 5B) and IL-6
(Supplemental Fig. 3B) exerted no such effect. Consistent
with these data, gdIL-15 T-APCs secreted substantial levels of
TNF-a but did not produce other DC-associated cytokines such
as IL-1b, IL-6, IL-10, IL-12p70, and IL-23 (Supplemental Fig. 4).
In addition to the polarizing effect of soluble TNF-a, we
observed a crucial contribution of gd T-APC expressed ICOSL
to the induction of IL-22 and AHR in naive CD4+ T cells (Fig.
5A, 5B). Neutralization of ICOSL did not affect CD4+ T cell
proliferation and viability (Supplemental Fig. 3A) nor expres-
sion of IFN-g and TBX21 (Fig. 5B) when assessed in cocultures
with gdIL-15 T-APCs, thus demonstrating the specificity of ICOSL
signaling for promoting IL-22 expression. Aside from the IL-22
promoting effects of ICOSL and TNF-a, we detected a prominent
FIGURE 5. Modulation of naive CD4+ T cell responses by polarizing cytokines and costimulatory molecules expressed by gd T-APCs. (A and B)
Cytokine and transcription factor profiles of naive CD4+ T cells cocultured with allogeneic gdIL-15 T-APCs in the absence or presence of neutralizing
reagents against IFN-g, CD70, ICOSL, or sTNFR. (C and D) Cytokine and transcription factor profiles of naive CD4+ T cells stimulated with anti-CD3/
CD28 mAbs in the presence of sCD70, TNF-a, IL-6, or agonistic mAbs against ICOS. Data were analyzed using Kruskal–Wallis tests combined with Dunn
multiple comparison tests compared with IgG1 (B) or medium controls (D). FACS plots are representative of $4 experiments using cells from $4 donors.
*p , 0.05, **p , 0.01, ***p , 0.001.
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role for gd T-APC–derived IFN-g and CD70 in driving upregulation
of IFN-g and TBX21 expression (Fig. 5A, 5B).
When assessing the polarizing efficiency of these signals in the
absence of APCs using anti-CD3/CD28 mAbs as stimulus,
recombinant TNF-a and inducible T-cell costimulator (ICOS)
agonists promoted CD4+ T cell expression of IL-22 and AHR
with comparable efficiency to that achieved by supplementation
with TNF-a and IL-6 (Fig. 5C, 5D) (12). In contrast, ligation of
CD27 on naive CD4+ T cells using soluble CD70 (sCD70) led to
increased expression of IFN-g and TBX21 (Fig. 5C, 5D), con-
sistent with a role for CD27 signaling in Th1 cell differentiation
(27). These findings underscore the functional relevance of co-
stimulatory molecule expression by activated Vg9/Vd2 T cells
and confirm a previously unknown role for ICOS signaling in the
induction of human IL-22 responses.
Gut-homing gd T-APCs enhance human colonic CD4+ T cell
responses and promote mucosal release of calprotectin
We next tested whether gd T-APCs are capable of modulating
cytokine production by CD4+ T cells isolated from human colon,
which contains significantly higher frequencies of memory cells
than are present in the blood (Fig. 6A). Both anti-CD3/CD28 Abs
and allogeneic gdIL-15 T-APCs triggered similar levels of prolif-
eration and IFN-g production by human colonic CD4+ T cells.
However, whereas anti-CD3/CD28 stimulation also increased
IL-17 production, gdIL-15 T-APCs instead skewed the response
toward production of IL-22, which was expressed by up to 50% of
all colonic CD4+ T cells (Fig. 6B). Combined blockade of TNF-a
and ICOSL inhibited IL-22 upregulation by colonic CD4+ T cells,
whereas neutralizing Abs against CD70 significantly impaired the
induction of IFN-g (Fig. 6C).
Supernatant concentrations of both IFN-g and IL-22 were in-
creased in HMB-PP–treated mucosal tissue cultures, whereas
IL-17 levels remained unchanged (Fig. 7A). HMB-PP also failed
to induce TNF-a, TGF-b, IL-4, or IL-10 secretion (data not shown).
Blocking experiments confirmed a major role for TNF-a/ICOSL
in driving intestinal IL-22 secretion and demonstrated a significant
influence of CD70 on IFN-g release by total colonic tissue cells
(Fig. 7B). Finally, we measured supernatant levels of the antimi-
crobial protein calprotectin, a heterodimeric complex of the metal
ion-binding proteins S100A8 (MRP8) and S100A9 (MRP14),
which is produced by epithelial cells in an IL-22–dependent
manner, as well as by myeloid lineage cells including gran-
ulocytes, monocytes, and tissue macrophages (28, 29). HMB-PP
stimulated a significant increase in mucosal tissue release of cal-
protectin in parallel with increased IL-22 secretion in both colon
(Fig. 7C) and ileum organ cultures (data not shown), but not upon
neutralization of TNF-a and ICOSL (Fig. 7C). Together, these
data reveal that TNF-a and ICOSL expressed by microbe-
responsive gd T cells induce key mediators of epithelial barrier
protection and anti-microbial immunity in the human intestine.
Discussion
This study demonstrates that microbial activation of humanVg9/Vd2
T cells in the peripheral blood, colon, and ileum stimulates
these cells to act as professional APCs that can efficiently polarize
CD4+ T cells toward specific effector fates distinct from those
induced by monocytes or DCs. Acquisition of gd T-APC function
was potently induced by microbial activation in the presence of
the epithelial-derived cytokine IL-15, suggesting a role in local
barrier defense via induction of IL-22 and calprotectin release,
whereas symbiosis-regulating Th17 responses may instead be
mediated by myeloid APCs. Although the unusual potential of
human Vg9/Vd2 T cells to act as professional APCs for MHC
class I– and MHC class II–restricted ab T cells was discovered
more than a decade ago (19), the qualitative nature and physio-
logical relevance of these responses has remained elusive until
now, in part due the fact that rodents lack a functional equivalent
of microbe-responsive gd T-APCs (20). Our data now demonstrate
that the striking plasticity of effector functions displayed by hu-
man Vg9/Vd2 T cells (30) can directly influence the cytokine
profile of responding CD4+ T cells, and that the capacity of gd
T-APCs to prime naive and memory CD4+ T cells critically depends
on microenvironmental factors present during APC generation. In
particular, we identified an unexpected requirement for IL-15 in
driving gd T-APCs to acquire a gut-homing phenotype and the
capacity to induce IL-22 production in CD4+ T cells. These
findings indicate that gd T-APCs and myeloid APCs provide
fundamentally different signals to CD4+ T cells.
The physiological relevance of gd T-APC–induced CD4+ T cell
responses was evident from our analyses of human intestinal or-
gan cultures, in which Vg9/Vd2 T cells were potent inducers of
IL-22 expression and promoted the release of calprotectin but not
IL-17. Our data demonstrate that human intestinal Vg9/Vd2
T cells efficiently upregulate APC features ex vivo, and that this
process may readily occur under physiological conditions in vivo
where IL-15 is abundantly expressed by the gut epithelium (31,
32) and HMB-PP is produced by the majority of the intestinal
FIGURE 6. Polarization of human colonic CD4+ T cells. (A) Intracel-
lular cytokine expression by freshly isolated colonic CD4+ T cells (Fresh),
and by colonic CD4+ T cells cocultured for 9 d with allogeneic gdIL-15
T-APCs or anti-CD3/CD28 mAbs. (B) Colonic CD4+ T cell responses to
allogeneic gdIL-15 T-APCs or anti-CD3/CD28 mAbs. (C) Inhibition of the
gdIL-15 T-APC–dependent cytokine secretion by colonic CD4
+ T cells in
the presence of the indicated blocking reagents, expressed relative to
controls cultured without APCs (100%) and cocultured with allogeneic
gdIL-15 T-APCs (0%). Data were analyzed using Kruskal–Wallis tests
combined with Dunn multiple comparison tests versus controls in the
absence of APCs. FACS plots are representative of $4 experiments using
cells from $4 donors. *p , 0.05, **p , 0.01.
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microbiota (23). Indeed, while Vg9/Vd2 T cells comprise a
sizeable fraction of circulating T cells, they are readily recruited to
epithelial sites including the skin and intestine, which are subject
to microbial challenge (17, 33, 34). Activation of Vg9/Vd2 T cells
in human intestine may therefore represent an effective mecha-
nism of sensing breaches in the gut barrier and eliciting local
protection via IL-22 induction without altering mucosal levels of
the prosymbiotic cytokine IL-17 (35), which alters intestinal
permeability and exacerbates gut inflammation in patients (36,
37). Our observation that the induction of IL-22 responses in
CD4+ T cells by gd T-APCs does not require the inflammatory
mediator IL-6, which is a key driver of Th22 differentiation in
other settings (12), further suggests a role for gd T cells in im-
mune surveillance in the healthy gut.
The failure of gd T-APCs to produce DC-associated polar-
izing cytokines prompted us to consider alternative signals in
driving IL-22 production in CD4+ T cells. Classically, CD4+
T cell polarization is thought to be predominantly mediated via
soluble factors, whereas the influence of costimulatory inter-
actions has been largely overlooked. Our findings identify a
novel ICOSL-dependent pathway that polarizes CD4+ T cells
toward expression of IL-22 and AHR, which evokes an earlier
report of a role for OX40L in polarizing CD4+ T cells toward a
follicular T helper cell phenotype (38). This unexpected role for
ICOSL in promoting IL-22 expression and calprotectin release
from human mucosal tissues has major implications for host
protection against microbial infection and inflammation. Be-
cause functional IL-22 receptors are expressed by non-immune
cells and epithelial IL-15 is ubiquitous not only in the intestine
but also in the skin, lung, liver, pancreas, and kidney (4–6), it is
likely that our findings apply to the modulation of tissue ho-
meostasis and inflammation at epithelial barriers in multiple
organs (6, 13, 39, 40).
IL-22 is a critical mediator of gut barrier defense against bac-
terial pathogens (41) and underpins therapeutic helminth infection
in human colitis (42). In particular, IL-22 triggers the production
of antimicrobial mediators including calprotectin, which exerts
complex effects on the intestinal microbiota by sequestering
essential metal ions (43), inducing epithelial shedding of fucosy-
lated host proteins for metabolism by luminal bacteria (44), and
modulating neutrophil functions (45, 46). These effects may radically
alter the balance of microbial species that colonize the gut, thus
providing effective protection against opportunistic pathogens and
chemical-induced colitis (47), but also suppressing commensal spe-
cies to assist Salmonella growth and dissemination from the inflamed
gut (3, 48, 49). Accordingly, calprotectin levels in the stool are a
reliable indicator of mucosal inflammation and can be used to predict
relapse in IBD (50). Our findings therefore uncover new potential
targets for therapeutic interventions and may in part explain the
beneficial outcomes in patients receiving azathioprine (18).
In summary, we have defined an unexpected role for human
microbe–responsive gd T cells in immune surveillance of human
tissues by instructing the cytokine profile of newly primed CD4+
T cells and modulating pre-existing memory CD4+ T cell func-
tion in blood and intestine. The mechanisms described in this
study are likely to contribute to epithelial immunosurveillance
and barrier protection at multiple other sites that are continu-
ously exposed to commensal, pathogenic, and environmental
microbes (22). The discovery that ICOSL functions as novel
modulator of IL-22 responses will also open new avenues for the
treatment of human inflammatory disorders including psoriasis,
arthritis, and IBD.
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FIGURE 7. ICOSL-/TNF-a–dependent
secretion of IFN-g, IL-22, and calprotectin
by HMB-PP–stimulated human colon. (A)
Cytokine secretion by total colon biopsy
cells cultured for 3 d with IL-2 and IL-15,
in the absence or presence of HMB-PP. (B)
Inhibition of the HMB-PP induced cytokine
secretion and calprotectin release from
colon organ cultures using the indicated
blocking reagents, expressed relative to
controls cultured without blocking reagents
in the absence (100%) and presence (0%) of
HMB-PP. (C) Secretion of calprotectin by
colonic biopsy cells cultured as in (A), and
inhibition of the HMB-PP induced release
of calprotectin using sTNFR and anti-
ICOSL. Data were analyzed using Wil-
coxon matched-pairs signed rank tests (B)
or Friedman tests combined with Dunn
multiple comparison tests (C) compared
with HMB-PP stimulated controls cultured
without blocking reagents.
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Supplemental Figure 1.  Cytokine-dependent expression of APC markers by Vγ9/Vδ2 T-
cells.  Expression of CD40, CD80, CD83 and CCR7 by freshly isolated Vγ9/Vδ2 T-cells and 
by γδ T-APCs generated over three days in the presence of HMB-PP with the indicated 
cytokines, as gated on live single Vγ9+ T-cells.  Data were analysed using Kruskal-Wallis tests 15 
combined with Dunn’s multiple comparisons tests versus freshly isolated cells.  Each data 
point represents an individual donor; asterisks depict significant differences.  Horizontal lines 
display the median, error bars indicate the interquartile range. 
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Supplemental Figure 2.  APC-dependent polarisation of naïve CD4+ T-cells.  Naïve CD4+ 
T-cells were co-cultured with γδ T-APCs generated under different conditions, in comparison 
with immature DCs (iDC), LPS or PGN-matured DCs (mDCLPS, mDCPGN), freshly isolated 
monocytes (mono), and LPS or PGN stimulated monocytes (monoLPS, monoPGN) from 5 
mismatched donors at an APC:responder ratio of 1:10; CD4+ T-cells cultured alone (w/o APC) 
served as controls.  (A) Cytokine secretion as assessed by ELISA after nine days in culture 
upon restimulation with PMA/ionomycin for 24 hours.  (B) Cytokine profile of naïve CD4+ T-
cells stimulated by allogeneic γδIL-15 T-APCs as determined after nine days upon restimulation, 
compared to mDCPGN.  Data were analysed using Kruskal-Wallis tests combined with Dunn’s 10 
multiple comparisons tests versus controls without APCs.  Each data point represents an 
individual donor; asterisks depict significant differences.  Horizontal lines display the median, 
error bars indicate the interquartile range.  FACS plots are representative of at least four 
experiments using cells from at least four individual donors.  
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Supplemental Figure 3.  Effect of co-stimulatory interactions on proliferation, viability 
and cytokine profiles of naïve CD4+ T-cells.  (A) CFSE-labelled naïve CD4+ T-cells were co-
cultured with γδIL-15 T-APCs from an allogeneic donor at an APC:responder ratio of 1:10.  10 
CD4+ T-cell proliferation in the absence or presence of blocking antibodies was assessed by 
flow cytometry after five days and is displayed as percentage of CFSElo cells.  Viability was 
assessed by flow cytometry after nine days and displayed as percentage of CD4+ T-cells 
negative for dead cell staining.  (B) Intracellular cytokine expression by naïve CD4+ T-cells in 
response to allogeneic γδIL-15 T-APCs co-cultured in the absence or presence of blocking 15 
antibodies, as determined by flow cytometry after nine days upon restimulation with 
PMA/ionomycin for 5 hours.  Data were analysed using Kruskal-Wallis tests combined with 
Dunn’s multiple comparisons tests versus IgG1 controls.  Each data point represents an 
individual donor; asterisks depict significant differences.  Horizontal lines display the median, 
error bars indicate the interquartile range. 20 
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Supplemental Figure 4.  Cytokine profile of distinct APC populations.  Purified Vγ9/Vδ2 
T-cells were cultured in medium or stimulated with 10 nM HMB-PP alone and different 
common γ-chain cytokines for 24 hours.  Immature DCs (iDC) and freshly isolated monocytes 
(mono) cultured in medium only or stimulated overnight with LPS or PGN served as controls.  5 
Cytokine levels in the culture supernatants were determined by ELISA.  Data were analysed 
using Kruskal-Wallis tests combined with Dunn’s multiple comparisons tests versus γδmed 
controls.  Each data point represents an individual donor; asterisks depict significant 
differences.  Horizontal lines display the median, error bars indicate the interquartile range. 
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